Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -9.78%91.04M | -37.81%192.27M | -29.56%100.91M | 50.59%309.18M | 52.36%143.25M | 79.43%205.31M | 75.53%94.02M | -7.96%114.43M | 47.80%53.57M | 1.44%124.32M |
| Operating income | -9.78%91.04M | -37.81%192.27M | -29.56%100.91M | 50.59%309.18M | 52.36%143.25M | 79.43%205.31M | 75.53%94.02M | -7.96%114.43M | 47.80%53.57M | 1.44%124.32M |
| Cost of sales | 12.57%-82.93M | 39.32%-184.43M | 31.18%-94.85M | -43.96%-303.93M | -31.85%-137.84M | -90.88%-211.12M | -99.34%-104.54M | 8.21%-110.6M | -47.50%-52.44M | -1.89%-120.5M |
| Operating expenses | 12.57%-82.93M | 39.32%-184.43M | 31.18%-94.85M | -43.96%-303.93M | -31.85%-137.84M | -90.88%-211.12M | -99.34%-104.54M | 8.21%-110.6M | -47.50%-52.44M | -1.89%-120.5M |
| Gross profit | 33.96%8.11M | 49.28%7.84M | 11.72%6.05M | 190.46%5.25M | 151.51%5.42M | -251.78%-5.81M | -1,036.99%-10.52M | 0.02%3.83M | 63.44%1.12M | -10.79%3.82M |
| Selling expenses | ---- | 8.26%-12.44K | 0.00%-1.8K | 45.36%-13.56K | 0.00%-1.8K | 52.08%-24.82K | 88.42%-1.8K | -8.93%-51.8K | 66.85%-15.55K | 14.96%-47.55K |
| Administrative expenses | 1.68%-1.49M | -28.02%-4.9M | -3.66%-1.52M | -21.91%-3.83M | -12.97%-1.47M | 10.53%-3.14M | 12.30%-1.3M | -1.26%-3.51M | -1.31%-1.48M | -8.21%-3.47M |
| Special items of operating profit | -86.35%150.93K | 451.68%6.79M | 202.15%1.11M | 81.39%1.23M | -45.92%366.06K | -58.66%678.84K | -24.91%676.87K | -53.84%1.64M | 25.07%901.38K | 3,093.52%3.56M |
| Operating profit | 20.00%6.77M | 268.15%9.72M | 30.61%5.64M | 131.82%2.64M | 138.75%4.32M | -535.67%-8.29M | -2,203.97%-11.14M | -50.76%1.9M | 634.31%529.52K | 239.86%3.87M |
| Financing cost | 32.91%-167.7K | 32.97%-437.5K | 26.14%-249.95K | -54.46%-652.67K | -96.56%-338.41K | -19.33%-422.55K | 10.63%-172.17K | 34.93%-354.09K | 38.17%-192.66K | 9.51%-544.13K |
| Earning before tax | 22.45%6.6M | 367.08%9.28M | 35.43%5.39M | 122.79%1.99M | 135.17%3.98M | -662.49%-8.72M | -3,458.35%-11.31M | -53.35%1.55M | 182.03%336.87K | 519.47%3.32M |
| Tax | -255.96%-1.27M | -69.01%-328.1K | -340.93%-356.56K | -150.97%-194.13K | -55.54%-80.87K | 87.98%-77.35K | 57.53%-51.99K | -18.70%-643.71K | -993.24%-122.43K | -12.59%-542.29K |
| After-tax profit from continuing operations | 5.91%5.33M | 399.36%8.95M | 29.10%5.03M | 120.38%1.79M | 134.30%3.9M | -1,070.74%-8.79M | -5,399.96%-11.37M | -67.41%905.85K | 154.02%214.44K | 4,991.88%2.78M |
| Earning after tax | 5.91%5.33M | 399.36%8.95M | 29.10%5.03M | 120.38%1.79M | 134.30%3.9M | -1,070.74%-8.79M | -5,399.96%-11.37M | -67.41%905.85K | 154.02%214.44K | 4,991.88%2.78M |
| Minority profit | 179.20%3.72K | ---2.41K | ---4.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 5.74%5.33M | 399.49%8.95M | 29.22%5.04M | 120.38%1.79M | 134.30%3.9M | -1,070.74%-8.79M | -5,399.96%-11.37M | -67.41%905.85K | 154.02%214.44K | 4,991.88%2.78M |
| Basic earnings per share | 6.35%0.0067 | 409.09%0.0112 | 28.57%0.0063 | 120.00%0.0022 | 134.51%0.0049 | -1,100.00%-0.011 | -4,833.33%-0.0142 | -68.57%0.0011 | 160.00%0.0003 | 3,400.00%0.0035 |
| Diluted earnings per share | 6.35%0.0067 | 409.09%0.0112 | 28.57%0.0063 | 120.00%0.0022 | 134.51%0.0049 | -1,100.00%-0.011 | -4,833.33%-0.0142 | -68.57%0.0011 | 160.00%0.0003 | 3,400.00%0.0035 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.